---
title: "Methyldopa - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db00968-mesh-d006973-1.html
toc: false 
---


Path ID: `DB00968_MESH_D006973_1`
{% include image.html url="images/db00968-mesh-d006973-1.png" file="db00968-mesh-d006973-1.png" alt="db00968-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008750 | methyldopa | Drug |
| CHEBI:141146 | α-methylnoradrenaline | ChemicalSubstance |
| UniProt:P08913 | Alpha-2A adrenergic receptor | Protein |
| UniProt:P18089 | Alpha-2B adrenergic receptor | Protein |
| UniProt:P18825 | Alpha-2C adrenergic receptor | Protein |
| GO:0048242 | epinephrine secretion | BiologicalProcess |
| GO:0048243 | norepinephrine secretion | BiologicalProcess |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| HP:0032263 | Increased blood pressure | PhenotypicFeature |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Methyldopa | HAS METABOLITE | Α-Methylnoradrenaline |
| Α-Methylnoradrenaline | INCREASES ACTIVITY OF | Alpha-2A Adrenergic Receptor |
| Α-Methylnoradrenaline | INCREASES ACTIVITY OF | Alpha-2B Adrenergic Receptor |
| Α-Methylnoradrenaline | INCREASES ACTIVITY OF | Alpha-2C Adrenergic Receptor |
| Alpha-2A Adrenergic Receptor | NEGATIVELY REGULATES | Epinephrine Secretion |
| Alpha-2B Adrenergic Receptor | NEGATIVELY REGULATES | Epinephrine Secretion |
| Alpha-2C Adrenergic Receptor | NEGATIVELY REGULATES | Epinephrine Secretion |
| Alpha-2A Adrenergic Receptor | NEGATIVELY REGULATES | Norepinephrine Secretion |
| Alpha-2B Adrenergic Receptor | NEGATIVELY REGULATES | Norepinephrine Secretion |
| Alpha-2C Adrenergic Receptor | NEGATIVELY REGULATES | Norepinephrine Secretion |
| Epinephrine Secretion | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Norepinephrine Secretion | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Comment: The active metabolite is an agonist of the presynaptic α2-adrenergic receptor in the CNS. These are inhibitory receptors that when activated cause inhibition of neurotransmitter release, which inhibits vasoconstriction.

Reference: 
  - [https://go.drugbank.com/drugs/DB00968](https://go.drugbank.com/drugs/DB00968)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL459/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL459/)
  - [https://en.wikipedia.org/wiki/Methyldopa#Mechanism_of_action](https://en.wikipedia.org/wiki/Methyldopa#Mechanism_of_action)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/38853](https://pubchem.ncbi.nlm.nih.gov/compound/38853)
  - [https://en.wikipedia.org/wiki/Corbadrine](https://en.wikipedia.org/wiki/Corbadrine)
  - [https://meshb.nlm.nih.gov/record/ui?ui=D008771](https://meshb.nlm.nih.gov/record/ui?ui=D008771)
  - [https://en.wikipedia.org/wiki/Antihypertensive_drug#Alpha-2_adrenergic_receptor_agonists](https://en.wikipedia.org/wiki/Antihypertensive_drug#Alpha-2_adrenergic_receptor_agonists)
  - [https://en.wikipedia.org/wiki/Adrenaline#Mechanism_of_action](https://en.wikipedia.org/wiki/Adrenaline#Mechanism_of_action)
  - [https://www.rxlist.com/aldomet-drug.htm#clinpharm](https://www.rxlist.com/aldomet-drug.htm#clinpharm)
